Status:

UNKNOWN

Hemodynamic Management in Women With SHS

Lead Sponsor:

China Medical University, China

Conditions:

Supine Hypotensive Syndrome

Eligibility:

FEMALE

22-45 years

Phase:

NA

Brief Summary

Supine hypotensive syndrome often occurs following spinal anesthesia for cesarean delivery.In our study we base the regulation and drug administration both on the regular monitor and on a novel monito...

Eligibility Criteria

Inclusion

  • American Society of Anesthesiologists (ASA) Physical Status Classification II and had no significant cardiovascular, pulmonary, renal or endocrine disease, without contraindications to CSEA,and could be diagnosed as SHS according to the criteria.

Exclusion

  • Patients undergoing emergency CD, CD under general anesthesia or patients' refusal to participate, or multiple fetations.

Key Trial Info

Start Date :

April 17 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2023

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05341362

Start Date

April 17 2022

End Date

June 1 2023

Last Update

March 7 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

China Medical University

Shenyang, Liaoning, China, 110000

Hemodynamic Management in Women With SHS | DecenTrialz